A Phase 3 interventional study of Lidocaine in Healthy, sponsored by Hospital Militar de Santiago. Status unknown at 1 site in Chile. Open to female participants aged 18 Years to 40 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2008-01-11.
Sponsored by Hospital Militar de Santiago · Phase 3, Interventional, and Treatment
RCT of S/E of lidocaine infiltration in tumescent technique.
This is the only study on the registry with Hospital Militar de Santiago as lead sponsor.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
Infiltration with 0.9% saline+1:1,000,000 epinephrine+0.06% Lidocaine
Drug: Lidocaine
Infiltration with 0.9% saline+1:1,000,000 epinephrine
Drug: Lidocaine
Subcutaneous infiltration with Active/Placebo solutions with tumescent technique previous to suction assisted lipectomy. Patient abdomen and back will be divided in 4 zones anterior and posterior, one side (left or right) will be infiltrated with active solution and the other with placebo. The allocation of the side will be made with random numbers.
Pain (VSA)
Time frame: 1, 6, 12, 18 and 24 post operative hours
Rescue medication
Time frame: 1, 6, 12, 15 and 24 hours postoperative
Nausea, emesis, arrythmia, seizures, arrest, shock, death.
Time frame: 24 hours postoperative
This study is status unknown, as verified in Dec 2007. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.